Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue 8, 2014, Pages 686-692

  Landau, Zohar ^a   Klonoff, David ^b   Nayberg, Irina ^b   Feldman, Dmitry ^a   Levit, Shmuel Boris ^c   Lender, Dan ^d   Mosenzon, Ofri ^d   Raz, Itamar ^d   Wainstein, Julio ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

^b DIABETES RESEARCH INSTITUTE   (United States)

^c SHEBA MEDICAL CENTER   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Insulin; Pharmacodynamic; Pharmacokinetic

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN LISPRO; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; APPLICATION SITE INFLAMMATION; APPLICATION SITE IRRITATION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE SAFETY; DIABETIC PATIENT; DISEASE DURATION; DRUG ABSORPTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HEATING; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL PATCH; WARMING; ADOLESCENT; ADVERSE EFFECTS; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 1; DRUG DELIVERY SYSTEM; HEAT; HYPERGLYCEMIA; INSULIN INFUSION; MIDDLE AGED; MULTICENTER STUDY; SKIN ABSORPTION; SKIN TEMPERATURE; UPREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DRUG DELIVERY SYSTEMS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HOT TEMPERATURE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN ASPART; INSULIN INFUSION SYSTEMS; INSULIN LISPRO; MALE; MIDDLE AGED; SKIN TEMPERATURE; SUBCUTANEOUS ABSORPTION; UP-REGULATION; YOUNG ADULT;

EID: 84906533020     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2536     Document Type: Article

References (14)

1. Heinemann L. Variability of insulin absorption and insulin action. Diabetes Technol Ther 2002; 4(5): 673-682.
2. Sindelka G, Heinemann L, Berger M, Frenck W, Chantelau E. Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia 1994; 37(4): 377-380.
3. Koivisto VA. Sauna-induced acceleration in insulin absorption from subcutaneous injection site. Br Med J 1980; 280(6229): 1411-1413.
4. Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Clin Ther 2009; 31(5): 980-987.
5. Freckmann G, Pleus S, Westhoff A, et al. Clinical performance of a device that applies local heat to the insulin infusion site: a crossover study. J Diabetes Sci Technol 2012; 6(2): 320-327.
6. Cengiz E, Weinzimer SA, Sherr JL, et al. Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device. Pediatr Diabetes 2013; 14(3): 168-173.
7. Cengiz E, Weinzimer SA, Sherr JL, et al. Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming. Diabetes technology & therapeutics 2014; 16(1): 20-25.
8. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237(3): E214-223.
9. Heinemann L, Anderson JH Jr. Measurement of insulin absorption and insulin action. Diabetes Technol Ther 2004; 6(5): 698-718.
10. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of areas under curves in diabetes research. Diabetes care 1995; 18(2): 245-250.
11. Ratner R, Wynne A, Nakhle S, Brusco O, Vlajnic A, Rendell M. Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096). Diabetes Obes Metab 2011; 13(12): 1142-1148.
12. Wutte A, Plank J, Bodenlenz M, et al. Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 2007; 115(7): 461-467.
13. Swan KL, Weinzimer SA, Dziura JD, et al. Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care 2008; 31(1): 44-46.
14. Swan KL, Dziura JD, Steil GM, et al. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care 2009; 32(2): 240-244.